Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
Changemakers of the week: Laguna Food Pantry and The Rama Tree Foundation
BY THE OPTIMIST DAILY EDITORIAL TEAM Every day at The Optimist Daily, we share stories of solutions from around the globe. While we celebrate innovations ...
Read MoreHow to keep an eye on your eye health
As we age, we can become more vulnerable to developing age-related eye conditions, diseases, and vision loss. The best way to stave off, or ...
Read MoreThis is how Australia reduced plastic litter on its beaches by 30 percent
When it comes to reporting about plastic waste on beaches, the news is rarely good. But one report paints a more positive picture of ...
Read MoreCrab Trapper Whiskey: capturing invasive species and putting them in whiskey
An occasionally neglected fact of conservation is the encroachment of invasive species. Some non-native animals can wind up consuming all available resources for endangered ...
Read More
